JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263199

Human FBXO11 knockout HeLa cell lysate

Be the first to review this product! 리뷰 제출

|

(0 출판물)

FBXO11 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 5 bp deletion in exon 8 and Insertion of the selection cassette in exon 8.
2 이미지
Sanger Sequencing - Human FBXO11 knockout HeLa cell lysate (AB263199)
  • Sanger seq

Unknown

Sanger Sequencing - Human FBXO11 knockout HeLa cell lysate (AB263199)

Allele-2 : Insertion of the selection cassette in exon 8

Sanger Sequencing - Human FBXO11 knockout HeLa cell lysate (AB263199)
  • Sanger seq

Unknown

Sanger Sequencing - Human FBXO11 knockout HeLa cell lysate (AB263199)

Allele-1 : 5 bp deletion in exon 8

주요 정보

세포 유형

HeLa

Species or organism

Human

조직

Cervix

Knockout 검증

Sanger Sequencing

Mutation 정보

Knockout achieved by using CRISPR/Cas9, 5 bp deletion in exon 8 and Insertion of the selection cassette in exon 8.

질병

Adenocarcinoma

제품 세부 정보

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

제품 구성

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263199-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human FBXO11 knockout HeLa cell lysate", "number":"AB263199-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB263199-CMP01", "productcode":"" } ] } } }

특성 및 보관 정보

유전자명
FBXO11
유전자 편집 종류
Knockout
유전자 편집 방식
CRISPR technology
Knockout 검증
Sanger Sequencing
배송 시 보관 조건
Ambient - Can Ship with Ice
적절한 단기 보관 조건
-20°C
적절한 장기 보관 조건
-20°C

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

FBXO11 also known as F-box only protein 11 is a member of the F-box protein family which are characterized by an F-box motif a sequence of approximately 40 amino acids. It has an approximate mass of 114 kDa. FBXO11 participates in the ubiquitin-proteasome system by acting as a substrate-recognition component of SCF (SKP1-CUL1-F-box protein) ubiquitin ligase complexes. The protein is expressed in various tissues throughout the body including lung liver and skin.
Biological function summary

FBXO11 is involved in protein degradation and regulation of the cell cycle. It serves as an important component of the SCF ubiquitin ligase complex where it binds to specific substrates marking them for proteasomal degradation. FBXO11 plays an important role in cellular processes such as DNA damage response and cell growth regulation. By targeting specific proteins for degradation it regulates protein stability which is important for normal cellular proliferation.

Pathways

FBXO11 is critical in the TGF-beta signaling pathway and the apoptosis pathway. In the TGF-beta signaling pathway FBXO11 regulates the stability of inhibitory SMAD proteins like SMAD7 by targeting them for proteasomal degradation. This regulation impacts cellular responses to TGF-beta influencing processes like cell differentiation and immune responses. In apoptosis FBXO11 interacts with other proteins like BCL2 to influence cell survival and programmed cell death.

FBXO11 plays a role in specific types of cancer and developmental disorders. Mutations or dysregulation of FBXO11 have identified links to diffuse large B-cell lymphoma due to its ability to affect the degradation of BCL6— a transcriptional repressor involved in the development and growth of this cancer. In developmental disorders FBXO11 mutations have associations with conditions like the oculo-facio-cardio-dental syndrome illustrating its importance in normal developmental processes.

품질 관리

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

제품 프로토콜

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com